These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6642292)

  • 1. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications.
    Panak E; Maffrand JP; Picard-Fraire C; Vallée E; Blanchard J; Roncucci R
    Haemostasis; 1983; 13 Suppl 1():1-54. PubMed ID: 6642292
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Agents Actions; 1984 Jan; 14(1):109-12. PubMed ID: 6702507
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function.
    Picard-Fraire C
    Agents Actions Suppl; 1984; 15():68-75. PubMed ID: 6385655
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the antithrombotic efficacy of ticlopidine in man.
    Panak E; Blanchard J; Roe RL
    Agents Actions Suppl; 1984; 15():148-66. PubMed ID: 6385644
    [No Abstract]   [Full Text] [Related]  

  • 5. Ticlopidine: quo vadis? Subarachnoid hemorrhage.
    Ono H; Mizukami M; Kitamura K; Kikuchi H
    Agents Actions Suppl; 1984; 15():259-72. PubMed ID: 6385650
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview: pharmacology of ticlopidine.
    Gordon JL
    Agents Actions Suppl; 1984; 15():108-15. PubMed ID: 6385643
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis.
    Gröntoft KC; Mulec H; Gutierrez A; Olander R
    Scand J Urol Nephrol; 1985; 19(1):55-7. PubMed ID: 3895411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term ticlopidine treatment on platelet function and its tolerability in cerebrovascular disease.
    Carrieri P; Orefice G; Fioretti A; Indaco A; Carfagna S
    J Int Med Res; 1984; 12(5):286-91. PubMed ID: 6500168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocytopenia due to antibodies induced by ticlopidine].
    Claas FH; de Fraiture WH; Meyboom RH
    Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
    Verstraete M
    Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423
    [No Abstract]   [Full Text] [Related]  

  • 12. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of ticlopidine in chronic hemodialyzed patients. Counter-indication in future renal transplant receivers].
    Lang P; Plaisant B; Benoit G; Brasseur L; Charpentier B; Fries D
    Presse Med; 1985 Apr; 14(16):894-5. PubMed ID: 3158926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ticlid].
    Drouet L
    Soins; 1985 May; (454):I-II. PubMed ID: 3848119
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial.
    Knudsen JB; Kjøller E; Skagen K; Gormsen J
    Thromb Haemost; 1985 Jun; 53(3):332-6. PubMed ID: 3901391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oral ticlopidine on arachidonic acid products in human platelets.
    Bruno JJ; Chang LF; McSpadden MM; Yang D
    Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prodrug activation as a crucial difference. Prasugrel - a new ADP receptor antagonist].
    Alban S
    Pharm Unserer Zeit; 2009; 38(4):320-8. PubMed ID: 19572350
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine.
    Bastida E; Escolar G; Almirall L; Ordinas A
    Thromb Haemost; 1986 Jun; 55(3):333-7. PubMed ID: 3750263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview: clinical experiences with ticlopidine.
    Day HJ
    Agents Actions Suppl; 1984; 15():297-309. PubMed ID: 6385654
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet drugs in the management of patients with thrombotic disorders.
    Harker LA
    Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.